Orion Pharma Animal Health and Vetoquinol Enter Distribution Collaboration from 1 January 2015
Orion Pharma Animal Health and Vetoquinol have announced their collaboration regarding the distribution of Orion’s sedatives product family alpha-2 agonists and antagonist Dexdomitor, Domitor and Domosedan and Antisedan.
Vétoquinol will be the distributor in selected European countries for Orion sedative products. The collaboration is effective from 1 January 2015.
Vetoquinol is responsible for marketing the sedatives to customers in the UK, Germany, France, Ireland, the Netherlands, Belgium, Luxembourg and Italy.
Orion Pharma Animal Health vice-president Niclas Lindstedt said: "Orion Pharma Animal Health foresees that this new alliance with a dedicated and recognised partner will further strengthen the position with customers of the well-accepted Orion sedatives range."
Vetoquinol CEO Matthieu Frechin said: "The inclusion of the sedative products from Orion Pharma Animal Health in our pain and surgery product range will further reinforce our offer to our customers; it is a an additional proof of our willingness to be a partner of choice for all vet surgeons in the field of pain and anaesthesia."